of these cells. Previous data suggest that acute exacerbations of ulcerative colitis and Crohn's disease can be distinguished by different IgG subclass expression of mucosal immunocytes and a different IgG subclass production pattern oflamina propria lymphocytes. A procedure to obtain enough intestinal mononuclear cells from biopsy specimens to measure in vitro IgG and IgGI production in control subjects and various patient groups has been established. IgG2 could be measured in Crohn's disease and ulcerative colitis only, as the concentrations in control subjects were below the sensitivity ofthe ELISA method. We found that IgG and IgGI production correlated with the degree of local inflammation in both diseases, even in slightly inflamed mucosa, compared with control subjects. The proportion of IgGI subclass was significantly increased in severely inflamed mucosa of both ulcerative colitis and Crohn's disease patients. A major difference between Crohn's disease and ulcerative colitis mucosa is apparent in mild or no inflammation. In Crohn's disease mucosa in remission, the IgGl/IgG ratio is comparable with that in controls, yet ulcerative colitis mucosa still displays significantly increased proportions of IgGl. In addition, the IgG2/IgG ratio is 0-12 in ulcerative colitis and 019 in Crohn's disease patients. The results show the dependence of local IgG and IgGI production on the degree of inflammation and that an increase in subclass IgGl in ulcerative colitis is present at all stages, including remission. These findings support the hypothesis that different immunoregulatory mechanisms are involved in Crohn's disease and ulcerative colitis. Environmental stimuli or genetic background may be responsible for the observed differences.
The aetiology and pathogenesis of ulcerative colitis and Crohn's disease are still unknown, yet several phenomena make it likely that a disturbance of the mucosal immune system plays an important role in both. In this respect immunohistochemical examination has shown that cytoplasmic immunoglobulin G 
INTESTINAL CELL ISOLATION
Six to eight biopsy specimens used for cell isolation were immediately transferred into cold RPMI-1640 medium (Biochrom, Berlin, Germany). Single cells were obtained by a modified enzymatic technique.6 The specimens were washed several times in Ca/Mg free PBS (GIBCO, Berlin, Germany) and then incubated at 4°C overnight in culture medium (RPMI 1640 medium with 10% fetal calf serum (GIBCO), antibiotics (GIBCO), and fungizone (GIBCO)), containing collagenase CLSPA (Biochrom) and hyaluronidase (Sigma, Deisenhofen, Germany). The next day the cell suspension was incubated at 37°C for 60 minutes with constant stirring to release mononuclear cells. The digested specimens were passed through steel meshes with a pore size of 500 and 300 Fm. After thorough washing, the cells were put on a discontinuous Percoll density gradient with 70% Percoll, 30% Percoll and culture medium and centrifuged. IMNC could be harvested from the 70%/30% Percoll interface.
IMNC viability was >85%, as determined by trypan blue exclusion. In several experiments flow cytometry was performed with an aliquot of cells using anti-CD20 (clone L27), anti-CD3 (clone SK7) (Becton-Dickinson, Heidelberg, Germany) and anti-CD22 (clone Tol15) (Dako, Hamburg, Germany) using a protocol supplied by the companies. Some 400000 IMNC were seeded into each well of a 96 well microtitre plate and supplemented with 250 1t of culture medium. No stimulants were added. 
Results
We isolated IMNC from 78 patients. In this study, 29 patients with Crohn's disease, 19 patients with ulcerative colitis, three patients with unspecific colitis, and 12 patients without gastrointestinal disease were evaluated. Patients with inflammation of the ileum (Crohn's disease of the ileum or backwash ileitis in ulcerative colitis) were included in this study, but ileal inflammation was not counted in the disease scores. There were no patients with inflammation of the ileum only.
ISOLATION OF IMNC FROM BIOPSY SPECIMENS
With enzymatic digestion and density gradients we were able to isolate viable IMNC from specimens that were used for functional studies. With this technique we could obtain between 500 000 and 5 million cells from 6 to 8 specimens. Viability was always >85%. The cell number was dependent on the size of the specimens and (Fig 1, hatched bars) . Similar data were obtained when total IgG production was compared. Fig 2, open bars) . However, when local inflammation in the colonic segment was compared with the IgG and IgGI production in the same segment, we found a significant difference in ulcerative colitis patients (Fig 2 hatched bars) inflammation was higher, we tested the possibility that Crohn's disease patients with low IgG concentrations might have significantly different IgG2 proportions compared with ulcerative colitis patients. We found a further increase in the IgG2/IgG ratio (Fig 4) 
